The Conversation (0)
- WORLD EDITIONAustraliaNorth AmericaWorld
Mackie Research Analyst Neal Gilmer has givenMettrum Health Corp. (TSXV:MT) a 12 month target price of $3.00, a premium of 105% to the $1.46 price.
Mackie Research Analyst Neal Gilmer has given Mettrum Health Corp. (TSXV:MT.V) a 12 month target price of $3.00, a premium of 105% to the $1.46 price.
Watch the full report:
Latest News
Outlook Reports
Featured Agriculture Investing Stocks
Browse Companies
MARKETS
COMMODITIES
CURRENCIES